Related Experiment Video
Updated: Jun 16, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Published on: August 1, 2013
[Gd@C(82)(OH)(22)](n) nanoparticles induce dendritic cell maturation and activate Th1 immune responses
De Yang1, Yuliang Zhao, Hua Guo
1Tianjin Medical University, Research Center of Basic Medic Sciences, Cancer Institute and Hospital, Tianjin 300060, China.
Gadolinium-containing nanoparticles ([Gd@C(82)(OH)(22)](n)) mature dendritic cells, enhancing T-cell activation and Th1 immune responses. This nanoparticle is a potent activator for potential anticancer therapies.
Area of Science:
- Immunology
- Nanotechnology
- Materials Science
Background:
- Dendritic cells (DCs) are crucial for immune defense against pathogens and tumors.
- DC maturation is key to initiating effective adaptive immune responses.
- Understanding novel nanoparticle interactions with DCs is vital for immunotherapy development.
Purpose of the Study:
- To investigate the immunomodulatory effects of [Gd@C(82)(OH)(22)](n) nanoparticles on dendritic cells.
- To determine if [Gd@C(82)(OH)(22)](n) can induce DC maturation and enhance T-cell responses.
- To explore the potential of [Gd@C(82)(OH)(22)](n) in modulating Th1-polarized immunity.
Main Methods:
- Treatment of dendritic cells with [Gd@C(82)(OH)(22)](n) nanoparticles.
- Analysis of DC phenotypic maturation markers (cytokines, co-stimulatory molecules, MHC molecules).
- Assessment of DC functional maturation via allogeneic T-cell activation assays.
- Evaluation of Th1 immune responses in mice immunized with ovalbumin and [Gd@C(82)(OH)(22)](n).
Main Results:
- [Gd@C(82)(OH)(22)](n) induced phenotypic and functional maturation of dendritic cells.
- DCs treated with nanoparticles showed increased IL-12p70 production and upregulated CD80, CD83, CD86, and MHC molecules.
- [Gd@C(82)(OH)(22)](n) enhanced ovalbumin-specific Th1 immune responses in vivo, evidenced by increased IFN-gamma, IL-1beta, and IL-2 production.
Conclusions:
- [Gd@C(82)(OH)(22)](n) nanoparticles are potent activators of dendritic cells and Th1 immune responses.
- These findings provide mechanistic insight into the previously reported anticancer activities of [Gd@C(82)(OH)(22)](n).
- The nanoparticle demonstrates significant potential as an immunomodulatory agent for therapeutic applications.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

